5JCT
Crystal Structure of Human Pirin in complex with a Chemical Probe pyrrolidine 24
Summary for 5JCT
Entry DOI | 10.2210/pdb5jct/pdb |
Descriptor | Pirin, FE (III) ION, GLYCEROL, ... (6 entities in total) |
Functional Keywords | cupin, beta-barrel fold, inhibitor, complex, oxidoreductase |
Biological source | Homo sapiens (Human) |
Cellular location | Nucleus : O00625 |
Total number of polymer chains | 1 |
Total formula weight | 35185.60 |
Authors | Ali, S.,van Montfort, R. (deposition date: 2016-04-15, release date: 2017-01-11, Last modification date: 2024-01-10) |
Primary citation | Cheeseman, M.D.,Chessum, N.E.,Rye, C.S.,Pasqua, A.E.,Tucker, M.J.,Wilding, B.,Evans, L.E.,Lepri, S.,Richards, M.,Sharp, S.Y.,Ali, S.,Rowlands, M.,O'Fee, L.,Miah, A.,Hayes, A.,Henley, A.T.,Powers, M.,Te Poele, R.,De Billy, E.,Pellegrino, L.,Raynaud, F.,Burke, R.,van Montfort, R.L.,Eccles, S.A.,Workman, P.,Jones, K. Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen. J. Med. Chem., 60:180-201, 2017 Cited by PubMed Abstract: Phenotypic screens, which focus on measuring and quantifying discrete cellular changes rather than affinity for individual recombinant proteins, have recently attracted renewed interest as an efficient strategy for drug discovery. In this article, we describe the discovery of a new chemical probe, bisamide (CCT251236), identified using an unbiased phenotypic screen to detect inhibitors of the HSF1 stress pathway. The chemical probe is orally bioavailable and displays efficacy in a human ovarian carcinoma xenograft model. By developing cell-based SAR and using chemical proteomics, we identified pirin as a high affinity molecular target, which was confirmed by SPR and crystallography. PubMed: 28004573DOI: 10.1021/acs.jmedchem.6b01055 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.73 Å) |
Structure validation
Download full validation report